Cargando…

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function

Levetiracetam is a broad-spectrum antiepileptic drug commonly used in intensive care units (ICUs). The objective of this study is to evaluate the adequacy of levetiracetam dosing in patients with normal or augmented renal clearance (ARC) admitted to the ICU by population modelling and simulation. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilbao-Meseguer, Idoia, Barrasa, Helena, Asín-Prieto, Eduardo, Alarcia-Lacalle, Ana, Rodríguez-Gascón, Alicia, Maynar, Javier, Sánchez-Izquierdo, José Ángel, Balziskueta, Goiatz, Griffith, María Sánchez-Bayton, Quilez Trasobares, Nerea, Solinís, María Ángeles, Isla, Arantxa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540413/ https://www.ncbi.nlm.nih.gov/pubmed/34683983 http://dx.doi.org/10.3390/pharmaceutics13101690

Ejemplares similares

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
por: Bilbao-Meseguer, Idoia, et al.
Publicado: (2022)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
por: Alarcia-Lacalle, Ana, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
por: Soraluce, Amaia, et al.
Publicado: (2020)

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis
por: Valero, Ana, et al.
Publicado: (2021)

SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria
por: Barrasa, Helena, et al.
Publicado: (2020)

Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
por: Ibar-Bariain, Maitane, et al.
Publicado: (2019)

α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2021)

Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and monte carlo simulation
por: Barrasa González, H, et al.
Publicado: (2015)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Levetiracetam-induced severe acute granulomatous interstitial nephritis
por: Chau, Katrina, et al.
Publicado: (2012)

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014)

Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008)

Levetiracetam-induced pancytopenia
por: Alzahrani, Talal, et al.
Publicado: (2015)

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives
por: Torrecilla, Josune, et al.
Publicado: (2014)

Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy
por: Posar, Annio, et al.
Publicado: (2014)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007)

Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
por: Wright, Chanin, et al.
Publicado: (2013)

Levetiracetam-induced leukocytoclastic vasculitis
por: Gupta, Mrinal
Publicado: (2017)

Levetiracetam for the Prophylaxis of Migraine in Adults
por: Azeem, Gauhar M, et al.
Publicado: (2021)

Levetiracetam-induced gingival hyperplasia
por: James, J, et al.
Publicado: (2022)

Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats
por: Smith, Casey, et al.
Publicado: (2019)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
por: Ignacio-Mejía, Iván, et al.
Publicado: (2023)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
por: Osuntokun, Opeyemi Samson, et al.
Publicado: (2021)

Pneumatocele during sorafenib therapy: first report of an unusual complication
por: Sangro, Paloma, et al.
Publicado: (2017)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Levetiracetam as an alternative therapy for Tourette syndrome
por: Martínez-Granero, MA, et al.
Publicado: (2010)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
por: Aceves, Jose, et al.
Publicado: (2013)

Levetiracetam Use in the Critical Care Setting
por: DeWolfe, Jennifer L., et al.
Publicado: (2013)

Role of intravenous levetiracetam in status migrainosus
por: Farooq, Muhammad U., et al.
Publicado: (2007)

Levetiracetam Rectal Administration in Healthy Dogs
por: Peters, R.K., et al.
Publicado: (2014)

Intravenous levetiracetam in critically ill children
por: Incecik, Faruk, et al.
Publicado: (2016)

Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
por: Nita, Dragos A., et al.
Publicado: (2016)

Levetiracetam Adverse Drug Reaction: Pancytopenia
por: Gohil, Jayendra R., et al.
Publicado: (2018)

Efficacy of Levetiracetam in Treatment of Childhood Stuttering
por: Ghazavi, Mohammadreza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9rmceq846d8bs1qv26ni9g17k3